At the forefront of tobacco control research is Roberta Freitas-Lemos, an assistant professor and tobacco researcher affiliated with the Fralin Biomedical Research Institute at Virginia Tech. Freitas-Lemos highlights the complexity of tobacco regulation, which she characterizes as a “patchwork approach.” This fragmented regulatory landscape involves a variety of tools and policies aimed at reducing tobacco use, yet the cumulative effectiveness of these measures requires rigorous experimental evaluation. The ultimate goal is to identify evidence-based interventions that can decisively improve health outcomes by discouraging tobacco initiation and promoting cessation.

Among recent regulatory efforts, restrictions on tobacco flavorings, especially menthol, have garnered substantial attention. Menthol, a minty additive, masks the harshness of cigarette smoke and facilitates initiation, particularly among young and marginalized populations. Concurrently, taxation strategies aimed at inflating the cost of tobacco products seek to create economic disincentives for purchase. Freitas-Lemos and her team have conducted three interrelated studies, each published in the journal Tobacco Control, to explore diverse aspects of tobacco regulations—including marketing tactics that circumvent menthol restrictions, the behavioral impacts of flavor bans, and the effects of multiple taxation models on consumer choices.

One pivotal study delved into the marketing of menthol cigarette accessory products, which are designed to add menthol flavor to cigarettes outside of the cigarette itself. Such accessories pose a significant challenge to public health regulations intended to eliminate menthol in cigarettes, as they can effectively undermine the intended impact of flavor bans. By comparing advertisement language and marketing practices in the United States and Europe, researchers discerned a clear divergence: European outlets, where menthol accessories remain legal, market them overtly as cigarette flavor enhancers. In contrast, U.S. retailers, operating within menthol ban jurisdictions such as Massachusetts and California, rebrand these products as “air refreshers” or devices for “air filtering purposes,” thus masking their use with cigarettes.

This evolving marketing lexicon is an astute industry response designed to circumvent legal prohibitions and maintain the consumer demand for mentholated tobacco experiences. The introduction of products like aroma cards, flavor capsules, and sprays actively marketed under innocuous descriptors challenges regulators’ ability to enforce bans effectively. Understanding these tactics is critical; without vigilant monitoring, public health gains from flavor prohibitions may be significantly compromised. Freitas-Lemos emphasizes the necessity of scrutinizing how the tobacco industry adapts its messaging to sidestep regulatory frameworks, which ultimately threatens the integrity of public health policies.

In another study, Freitas-Lemos employed the Experimental Tobacco Marketplace, an innovative simulated online retail environment developed at the Fralin Biomedical Research Institute, to investigate behavioral shifts induced by flavor bans. The experimental design included twenty-five menthol cigarette smokers who were subjected to four scenarios featuring varying degrees of flavor restrictions across conventional cigarettes and e-cigarettes. The marketplace also included access to nicotine replacement therapies, such as gums and lozenges, allowing for a comprehensive analysis of substitution effects.

The findings illuminated consequential behavioral adaptations: prohibiting menthol in cigarettes resulted in reduced purchases of these products, with corresponding increases in e-cigarette consumption. When flavors were additionally banned in e-cigarettes, participants demonstrated heightened acquisition of nicotine replacement therapies. These outcomes suggest that policy interactions—the combined impact of flavor bans across multiple product categories—can influence tobacco users to transition toward less harmful alternatives or cessation aids. Such insights are invaluable for policymakers aiming to craft harmonized regulations that optimize public health benefits.

The final study in the series examined the role of taxation as a lever for modifying tobacco product consumption patterns. Utilizing the Experimental Tobacco Marketplace once again, researchers exposed nearly 400 participants to four distinctive tax structures. These included differential tax rates based on product certification for reduced health risks, nicotine content, harm reduction potential, and universal taxation across tobacco products but exemption of nicotine replacement therapies.

Results revealed that all tax policies succeeded in decreasing overall tobacco spending; however, tax schemes scaled according to nicotine content were most efficacious. This strategy not only substantially reduced expenditures but also motivated a shift toward untaxed nicotine replacement products, highlighting the power of economically incentivized harm reduction. Notably, these taxation effects manifested consistently across socioeconomic strata, an essential consideration given the disproportionate tobacco burden experienced by populations with lower income and educational attainment.

Collectively, Freitas-Lemos’ research underscores the intricate dynamics of tobacco regulation and industry countermeasures. Flavor bans must be accompanied by vigilant enforcement against product innovations that undermine restrictions, such as menthol accessories marketed under alternative guises. Policy coherence across tobacco and nicotine delivery products is essential to guide consumers toward less harmful options or cessation. Moreover, taxation strategies that discriminate based on product risk profiles can effectively steer consumer behavior while promoting health equity.

The impetus behind these scientific endeavors is unequivocal: tobacco remains a formidable cause of preventable morbidity and mortality worldwide despite prolonged public health campaigns. Disentangling the complex interplay between regulatory policies, consumer behavior, and industry strategies is critical in evolving effective tobacco control frameworks. Freitas-Lemos’ research offers empirically grounded insights to inform progressive legislation and public health initiatives striving to curb tobacco use and its devastating health consequences.

Funding support for these studies was provided by the National Institutes of Health and the Fralin Biomedical Research Institute. Additional backing came from the Lyerly Postdoctoral Excellence Award and the Red Gates Foundation, facilitating rigorous and policy-relevant tobacco control research.

Subject of Research: People

Article Title: Air refresher? Menthol cigarette accessory marketing in the USA and parallels in countries with menthol bans

News Publication Date: 25-Feb-2026

Web References: http://dx.doi.org/10.1136/tc-2025-059931

Image Credits: Clayton Metz/Virginia Tech

Keywords: Tobacco, Addiction, Human health

Over the past decade, vaping has experienced a dramatic surge in popularity, particularly among younger demographics. This increase correlates strongly with the widespread availability of inexpensive disposable vaping devices, which have become ubiquitous on retail shelves and online marketplaces. Such devices are often marketed with eye-catching colors and distinctive branding reminiscent of consumer electronics or lifestyle products, arguably enhancing their allure to adolescents and young adults. Prior research in tobacco control has established that packaging plays a crucial role in product appeal, demonstrating that colorful, brand-specific designs increase consumer interest and reduce perceptions of harm, especially among youth.

Recognizing that packaging regulations have previously been employed as a public health tool to reduce cigarette appeal, this study uniquely focuses on whether applying similar standardization directly to the devices themselves—in this case, disposable vapes—would yield comparable effects. To this end, the researchers conducted a randomized online experiment involving 15,259 participants from England, Canada, and the US, a sufficiently large and diverse sample for robust analysis. Participants were randomly divided into two groups, each exposed to images of four different disposable vaping devices: one group viewed vividly branded products, while the other was shown identical devices rendered in plain white without any branding or distinctive coloration.

The outcomes were telling. Participants exposed to the standardized, plain-coloured vapes reported significantly less interest in trying at least one of the devices compared to those in the branded group. Specifically, over 67% of the standardized group expressed no interest in any of the shown products, compared with just under 63% in the branded group. This difference, while moderate, reveals that visual and brand standardization may effectively dampen early curiosity or experimentation among youth and young adults.

Interestingly, the largest reduction in interest from standardization was observed not among those who had never previously vaped or smoked, but rather among recent smokers who had not vaped in the past month. In this group, nearly half of participants (47.5%) exposed to standardized devices reported no interest in trying them, compared with only 37.5% in the branded group. This finding points to an important potential consequence: while decreasing appeal among non-users and youth is desirable, reduced attractiveness among smokers who might otherwise switch to vaping—a less harmful alternative—could hinder public health progress.

Among individuals who exclusively vaped but did not smoke, there was similarly a small increase in disinterest when devices were standardized (20% vs. 16.5%). Patterns persisted among dual users (those who both smoked and vaped) and former users, with the standardized appearance consistently associated with higher proportions reporting no interest. These gradations across user groups underline the complexity of how design features influence consumer behavior across diverse segments of the young population.

Contrary to initial expectations, perceptions of harm were minimally affected by device standardization. Approximately 31% of participants viewing the standardized devices considered them less harmful than smoking, compared with roughly 33% in the branded group, a difference lacking clear statistical or practical significance. This suggests that color and branding influence appeal more than they alter underlying beliefs about relative health risks, highlighting the psychological distinction between product attractiveness and risk perception.

Such findings hold critical implications for policymakers. The UK government, among others, has announced intentions to regulate vape device packaging by imposing standardization measures, a shift toward stricter control reminiscent of historical anti-tobacco packaging strategies. However, concrete details about expected design restrictions remain unavailable. Therefore, this study provides timely evidence suggesting that extending regulation beyond packaging to the devices themselves could amplify deterrent effects on youth experimentation.

Nevertheless, the study authors caution about unintended trade-offs inherent in such policies. Given the reduction in interest observed among current smokers, overly stringent standardization might inadvertently slow transitions from combustible tobacco products to e-cigarettes—a transition widely recognized as beneficial for smoking cessation efforts. Additionally, discouraging switching could increase the risk of relapse to tobacco use or persistent dual consumption, with attendant negative public health impacts.

This tension underscores the necessity for a balanced regulatory approach, one that effectively mitigates youth uptake without compromising harm reduction opportunities for existing smokers. Complementary policies, such as targeted smoking cessation programs, educational campaigns, and perhaps tailored device standards, might be integrated to optimize outcomes. Further research is needed to explore these dynamics longitudinally and in diverse socioeconomic and cultural contexts.

In sum, this landmark study advances our understanding of how visual modifications to vape products influence product appeal among young people across three countries with different tobacco control landscapes. By isolating the effect of device color and branding, it provides a foundation for evidence-based policymaking aimed at reducing vaping initiation without sacrificing the potential public health gains from smoker substitution. As vaping regulations take shape worldwide, such data-driven insights will be invaluable in crafting nuanced, effective, and equitable tobacco harm reduction frameworks.

Subject of Research: People

Article Title: Impact of standardising the colour and branding of vape devices on product appeal among young people: a randomised experiment in England, Canada and the United States

News Publication Date: 20-May-2025

Web References: http://dx.doi.org/10.1136/tc-2024-059210

Keywords: Health and medicine

According to clinical findings published in the journal Tobacco Control, menthol cigarettes present a heightened mortality risk that surpasses that of their non-menthol counterparts. The analysis involved data from nearly one million individuals who participated in the Cancer Prevention Study II, a long-term prospective cohort study established in the early 1980s. Researchers meticulously tracked mortality outcomes over a six-year period, providing substantial evidence that suggests menthol smokers face increased risks from both all-cause mortality and heart-related diseases.

Particular attention was paid to specific demographic groups, notably Black participants, who exhibited a staggering 88% increase in mortality risks related to heart diseases when smoking menthol brands. These findings raise critical concerns regarding health disparities tied to menthol cigarette use, shedding light on the specific impact these products have on minority populations. The results underscore an urgent call to action for policymakers and public health officials to take steps toward regulating menthol cigarettes to protect at-risk communities.

Dr. Priti Bandi, the lead author of the study and scientific director of risk factors and screening research at ACS, emphasized the entrenched public health threat posed by menthol cigarettes. She stresses that their unique attributes contribute to higher rates of smoking initiation and decreased cessation efforts among users. Dr. Bandi’s assertion that menthol cigarettes need to be regulated to save lives aligns with a broader public health narrative that seeks to generate awareness about the dangers associated with flavored tobacco products.

Throughout the study, researchers utilized a robust analytical framework that categorized participants based on their smoking status—current, former, or never smokers—and whether they primarily smoked menthol or non-menthol cigarettes. This comprehensive methodology allowed for an in-depth examination of mortality outcomes across various smoking behaviors. By contrasting the health risks between these two groups, the researchers could quantify the repercussions of menthol cigarette consumption on overall health.

Among the participants studied, a significant number reported smoking menthol brands, with 73,486 individuals identified as menthol smokers, while 281,680 reported using non-menthol brands. Out of this population, there were notable numbers of deaths: 4,071 among menthol smokers and 20,738 among non-menthol smokers. These statistics underscore the need for ongoing research into the health implications of smoking habits and highlight the dangers associated with continued menthol cigarette use.

Furthermore, the research delved into the positive health impacts of quitting smoking, demonstrating that cessation from both menthol and non-menthol cigarettes substantially reduced health risks and mortality rates. Former smokers of menthol cigarettes presented an increased risk of 12% for all-cause mortality, 16% for all cardiovascular diseases, and a significant 43% increase for various heart ailments compared to their non-menthol counterparts. This aspect of the study reinforces the vital message of quitting smoking as a key step toward enhancing long-term health outcomes.

The study’s conclusions underscore an essential message: no form of cigarette smoking is safe. Dr. Bandi reiterated this sentiment by stating that the most dangerous choice is to continue smoking, irrespective of the cigarette’s menthol flavoring. Smokers are encouraged to seek cessation opportunities to mitigate their risk of severe health consequences and premature death. This message is particularly crucial in light of the evidence that quitting can lead to dramatic improvements in health and longevity.

Adding to the urgency of these findings, the president of ACS’s advocacy affiliate, Lisa A. Lacasse, urged policymakers to adopt comprehensive measures that support smoking cessation and discourage tobacco use among youths. Lacasse highlighted the importance of providing accessible resources to help individuals quit smoking and reiterated the organization’s commitment to advocating for strong tobacco control policies. Ensuring barrier-free access to cessation services, including support through quitlines and healthcare providers, is vital for fostering a healthier society.

Additionally, the researchers involved in this significant study included prominent figures in the field, such as Dr. Farhad Islami, Dr. Samuel Asare, and others committed to public health research. Their collective work aims to contribute to a growing body of evidence that advocates for impactful tobacco control measures in order to protect the health of future generations. The rigorous methodology employed in this study lays a strong foundation for future investigations into the broader consequences of menthol tobacco products on public health.

By disseminating these critical findings to the wider community, the American Cancer Society aims to affect change by prompting discussions and encouraging legislative actions that restrict the sales of menthol cigarettes. With a notable proportion of tobacco products in circulation being flavored, addressing this issue has significant implications for global tobacco control efforts.

In light of the shocking data regarding mortality risks associated with menthol cigarettes, it is clear that further research and advocacy are warranted. The fight against tobacco-related health problems is far from over, and studies like this highlight the necessity for continued vigilance in public health policy. By prioritizing the elimination of flavored tobacco products, particularly menthol cigarettes, health organizations can take substantial strides toward reducing the prevalence of smoking-related diseases and improving community health outcomes.

Ultimately, this pivotal research serves as a clarion call for action in the ongoing battle against tobacco use. The evidence presented by ACS underscores the dire need for regulatory measures that could save countless lives in the fight against preventable diseases caused by smoking. It is imperative that society collectively acknowledges the severity of the situation and commits to enacting policies that champion public health for the benefit of all.

Subject of Research: Study on the mortality risks associated with menthol vs. non-menthol cigarettes.
Article Title: New ACS Study Finds Menthol Flavored Cigarette Smoking Increases Mortality Risk vs. Non-Menthol Cigarettes.
News Publication Date: 13-Feb-2025.
Web References: American Cancer Society, Tobacco Control.
References: American Cancer Society research articles and findings.
Image Credits: American Cancer Society.

Keywords: Menthol cigarettes, mortality risk, tobacco control, smoking cessation, cardiovascular diseases, public health, American Cancer Society.